• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)

    2/13/23 2:03:31 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care
    Get the next $SGRY alert in real time by email
    SC 13G/A 1 surgery-sc13ga_123122.htm AMENDMENT TO FORM SC 13G

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     


     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 1)*

     

    Surgery Partners, Inc.

    (Name of Issuer)

     

    Common Stock, $0.01 par value per share

    (Title of Class of Securities)

     

    86881A100

    (CUSIP Number)

     

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. 86881A100

     

    1

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Durable Capital Partners LP

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a)       ☐

    (b)       ☐

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY 

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    5,672,185

     

    6

    SHARED VOTING POWER

     

    0       

     

    7

    SOLE DISPOSITIVE POWER

     

    5,672,185

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    5,672,185

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    4.6%

     

    12

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    IA, PN

     

           

     

     

    Item 1(a). Name of Issuer:

     

    Surgery Partners, Inc. (the “Issuer”)

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

    310 Seven Springs Way, Suite 500

    Brentwood, Tennessee 37027

     

    Item 2(a).Names of Person Filing:

     

    The name of the person filing this report is: 

    Durable Capital Partners LP (the “Reporting Person”)

     

    Item 2(b).Address of Principal Business Office or, if None, Residence:

     

    The address of the principal business office of the Reporting Person is: 

    4747 Bethesda Avenue, Suite 1002 

    Bethesda, Maryland 20814

     

    Item 2(c).Citizenship or Place of Organization:

     

    The Reporting Person is a limited partnership organized under the laws of the State of Delaware.

     

    Item 2(d).Title of Class of Securities:

     

    Common Stock, $0.01 par value per share (“Common Stock”)

     

    Item 2(e).CUSIP Number:

     

    86881A100

     

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     

    (b)☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

    (c)☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     

    (d)☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

     

    (e)☒ An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).

     

    (f)☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

     

     

     

     

    (g)☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

     

    (h)☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

     

    (i)☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).

     

    (j)☐ A non-U.S. institution that is the functional equivalent of any of the institutions listed in § 240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution.

     

    (k)☐ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    Item 4.Ownership.

     

    The information required by this item with respect to the Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are based on 122,603,695 outstanding shares of voting Common Stock, as reported in the Issuer’s Schedule 13D/A filed on December 27, 2022.

     

    Durable Capital Master Fund LP directly holds 5,672,185 shares of Common Stock (the “Shares”). The Reporting Person, as the investment adviser to Durable Capital Master Fund LP, has sole power to direct the vote and disposition of the Shares. Durable Capital Partners GP LLC (“Durable GP”) is the general partner of the Reporting Person, and Henry Ellenbogen is the chief investment officer of the Reporting Person and the managing member of Durable GP.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    See disclosure of relationships among parties under Item 4. The economic benefits of the Shares are shared based on agreements among the parties.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    See control and Shares holding disclosure in Item 4.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Inapplicable.

     

     

     

     

    Item 9.Notice of Dissolution of Group.

     

    Inapplicable.

     

    Item 10.Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date:    February 13, 2023

     

    DURABLE CAPITAL PARTNERS LP  
         
    By: /s/ Julie Jack   
      Name: Julie Jack  
      Title: Authorized Person  

     

     

    Get the next $SGRY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SGRY

    DatePrice TargetRatingAnalyst
    12/16/2024$30.00Buy
    BofA Securities
    10/14/2024$38.00Buy
    UBS
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    6/28/2024$31.00Outperform
    Macquarie
    3/6/2024$35.00Equal Weight
    Barclays
    11/14/2023$39.00 → $35.00Market Perform → Outperform
    TD Cowen
    6/2/2023$42.00 → $45.00Neutral → Buy
    BofA Securities
    5/12/2023$48.00Buy
    Mizuho
    More analyst ratings

    $SGRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities initiated coverage on Surgery Partners with a new price target

      BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00

      12/16/24 6:50:04 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • UBS initiated coverage on Surgery Partners with a new price target

      UBS initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $38.00

      10/14/24 7:41:50 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • KeyBanc Capital Markets initiated coverage on Surgery Partners

      KeyBanc Capital Markets initiated coverage of Surgery Partners with a rating of Sector Weight

      10/11/24 7:53:18 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $SGRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance

      BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan

      5/12/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details

      BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13752904 Interested investor

      4/18/25 2:09:12 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance

      BRENTWOOD, Tenn., March 03, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 17.5% for the fourth quarter and 13.5% for the full year Same-facility revenues increased 5.6% for the fourth quarter and 8.0% for the full yearSame-facility cases increased 5.1% for the fourth quarter and 3.9% for the full year Net

      3/3/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Surgery Partners Inc.

      SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

      11/8/24 10:46:38 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by Surgery Partners Inc.

      SC 13G - Surgery Partners, Inc. (0001638833) (Subject)

      10/24/24 2:02:10 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)

      SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

      2/13/24 5:15:54 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Exec Chairman of the Board Deveydt Wayne S was granted 4,233 shares, increasing direct ownership by 4% to 105,203 units (SEC Form 4)

      4 - Surgery Partners, Inc. (0001638833) (Issuer)

      3/25/25 4:32:57 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Chief Admin & Dev Officer Baldock Jennifer sold $14,651 worth of shares (612 units at $23.94), decreasing direct ownership by 0.26% to 236,047 units (SEC Form 4)

      4 - Surgery Partners, Inc. (0001638833) (Issuer)

      3/17/25 4:17:09 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Chief Human Resources Officer Burkhalter Danielle sold $1,760 worth of shares (74 units at $23.78), decreasing direct ownership by 0.16% to 44,839 units (SEC Form 4)

      4 - Surgery Partners, Inc. (0001638833) (Issuer)

      3/17/25 4:16:58 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

      SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

      5/14/25 12:24:27 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by Surgery Partners Inc.

      10-Q - Surgery Partners, Inc. (0001638833) (Filer)

      5/12/25 4:25:46 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form SCHEDULE 13G filed by Surgery Partners Inc.

      SCHEDULE 13G - Surgery Partners, Inc. (0001638833) (Subject)

      5/12/25 10:44:45 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Financials

    Live finance-specific insights

    See more
    • Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance

      BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan

      5/12/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details

      BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13752904 Interested investor

      4/18/25 2:09:12 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance

      BRENTWOOD, Tenn., March 03, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 17.5% for the fourth quarter and 13.5% for the full year Same-facility revenues increased 5.6% for the fourth quarter and 8.0% for the full yearSame-facility cases increased 5.1% for the fourth quarter and 3.9% for the full year Net

      3/3/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Leadership Updates

    Live Leadership Updates

    See more
    • Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors

      BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal

      1/13/25 5:00:24 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

      PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

      9/20/23 8:05:00 AM ET
      $SGRY
      $TDOC
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • Akumin Provides Business Update and Announces CFO Transition

      PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr

      8/12/22 5:56:00 PM ET
      $AKU
      $ELV
      $SGRY
      Medical Specialities
      Health Care
      Hospital/Nursing Management